News MS Symptoms, Coupled with Poor Self-Esteem, Can Lead to Serious Depression, Study Says MS Symptoms, Coupled with Poor Self-Esteem, Can Lead to Serious Depression, Study Says by Joana Fernandes, PhD | July 20, 2017 Share this article: Share article via email Copy article link Fatigue, limited mobility, and poor self-esteem or resiliency were found to be associated with periodsĀ of seriousĀ depression among multiple sclerosis (MS) patients, according to a recent study. The study, titled āDeterminants and incidence of depression in multiple sclerosis: A prospective cohort study,ā was published in the Journal of Psychosomatic Research. Previous researchĀ has suggested that MS patients are atĀ risk of major depression, with potentially profound impact on their quality of life.Ā But only a few studies have addressed the incidence of depression among MS patients or the risk factors that may underlie itsĀ occurrence. Researchers in CanadaĀ enrolled 188 MS patients being treated an Alberta clinic, who were interviewed to assessĀ potential risk factors for depression: namely, socioeconomic status, disease-related factors, childhood risk factors, psychosocial factors, and health behaviors. Participants were also asked to complete the Patient Health Questionnaire every two weeks for six months to identify depressive symptoms in real-time. Over a six-month follow-up, 36 cases of depression were reported among the group of MS patients analyzed. The incidence of depression was 0.019 for women, but higher āĀ 0.044 ā for men. Importantly, several factors seemed to be associated with depression in theseĀ patientsĀ āĀ fatigue, limited mobility, and low resiliency, self-esteem, and self-efficacy, as well as poor coping skills.Ā Results also showed that gender and income were associated with depression. Overall, the researchers concluded thatĀ “depression in MS exhibits a risk factor profile similar to that of depression in the general population, with the additional impact of MS illness-related factors. Potentially modifiable risk factors, such as coping with stress and resiliency, present opportunities for focus of further research in depression in MS treatment and prevention efforts.” Concerning treatment, the team also emphasized that “while there is evidence in the clinical context that supports the efficacy for pharmacologic and non-pharmacologic treatments for depression in the general population, there is currently insufficient evidence to support/or refute the efficacy of depression treatment for individuals with MSĀ … Clearly this is an area that requires additional research.” In related news People with multiple sclerosis who feel stigmatized because of their condition are more likely to have depression, research presented at the Consortium of Multiple Sclerosis Centers Annual MeetingĀ showed. TheĀ Pennsylvania State UniversityĀ research team said the impact of the stigma can be eased by lots of social support, a sense of belonging, and a sense of independence. Their study was based on information from the semiannual survey of theĀ North American Research Committee on Multiple Sclerosis, which coveredĀ 5,413 people with MS. The presentation was titledĀ āThe Contribution of Stigma to Depression Symptoms and Depression Status Among Individuals Living with Multiple Sclerosis.ā Print This Page About the Author Joana Fernandes, PhD Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology. Tags depression, fatigue, risk factors, self-efficacy, self-esteem
April 26, 2024 News by Margarida Maia, PhD Employment, income drop steadily over 2 decades after onset of MS
April 26, 2024 News by Marisa Wexler, MS Machine learning model predicts CIS to MS conversion risk: Study
April 25, 2024 Columns by Benjamin Hofmeister Finding safety while living with the constant threat of MS progression